Miroculus Stock

Miroculus is a hands off sample-to-answer solution for molecular testing.

About Miroculus Stock

Miroculus is a hands off sample-to-answer solution for molecular testing. Miroculus delivers assay flexibility and automation capacity in an affordable digital microfluidics platform, which enables seamless workflow integration from novel molecular protocols to data analytics.

Funding History

January 2014	$0
September 2014	$500K
April 2015	$2.3M
May 2016	$50K
October 2016	$0
August 2018	$17.2M

Management

CTO

Jorge Soto

Chief Scientific Officer

Foteini Christodoulou

CEO

Alejandro Tocigl

Other Companies

Learn More

CardioDx

CardioDx is a cardiovascular genomic diagnostics company providing clinicians with information to enhance patient care.

Cloud-based health information technology software

11Age (years)

$128MTotal Funding

Learn More

Frequency Therapeutics

Small, molecular progenitor cells drugs

Infor offers enterprise software for CRM, ERP, HRM, financial management, performance management, and supply chain management.

18Age (years)

$2.5BTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Miroculus or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 100K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2020 EquityZen Inc. All rights reserved.